Effect of Hormonal Replacement Therapy on Nocturia in Postmenopausal Women
NCT04433897 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2024-04-12
Summary
Aim of this study was to observe
The study was adjusted in two parts:
PART 1 is a crossectional study in which the prevalance, risk factors and etiology of nocturia among postmenopausal women is assessed.
PART 2 is a cohort study observing the impact of 10 different hormonal substitution therapies on nocturia.
Conditions
- Nocturia
Interventions
- OTHER
-
Questionnaire
All women fulfilled 3 questionairres * TANGO * ICIQ -N * Perceived Stress Scale
Sponsors & Collaborators
-
University Hospital, Ghent
lead OTHER
Eligibility
- Min Age
- 40 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-01
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women
NCT06508944 ·Status: COMPLETED ·Phase: PHASE4
-
No More Sleepless Nights in Perimenopause
NCT06497894 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death
NCT00580775 ·Status: COMPLETED
-
Hormone Replacement Trial Against ALzheimers' Disease
NCT04312399 ·Status: RECRUITING ·Phase: NA
-
Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream
NCT05723601 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS
NCT02033512 ·Status: COMPLETED ·Phase: PHASE2
-
Hormone Replacement Therapy and Insulin Action: A Double-Blind, Parallel, Placebo-Controlled Hormone Intervention Study in Postmenopausal Women
NCT00005769 ·Status: UNKNOWN ·Phase: PHASE2
-
Reciprocal Influence of Sex Steroid Environment and Adipocyte Function in Men
NCT00740194 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness
NCT05280028 ·Status: RECRUITING
-
Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms
NCT00465894 ·Status: COMPLETED ·Phase: NA
-
Perception of Efficacy, Safety and Tolerability of Three Non-hormonal Intravaginal Gels and Hormone Cream
NCT02987647 ·Status: UNKNOWN ·Phase: PHASE4
-
The Outcome of Chinese Women With Genitourinary Syndrome of Menopause Treated With Vaginal Dehydroepiandrosterone
NCT05434351 ·Status: TERMINATED
-
Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy
NCT01487304 ·Status: COMPLETED
-
Effect of Vaginal Estrogen on Alterations in the Urine Microbiome of Menopausal Women With Overactive Bladder
NCT06780163 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women
NCT00592839 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
NCT00349791 ·Status: COMPLETED ·Phase: PHASE3
-
Symptom Monitoring and Menopausal Symptoms
NCT05603234 ·Status: COMPLETED ·Phase: NA
-
Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen
NCT00384046 ·Status: COMPLETED ·Phase: PHASE3
-
Multi-centre Clinical Trial on Hormone Replacement Treatment in China
NCT01698164 ·Status: UNKNOWN ·Phase: PHASE4
-
Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women
NCT01477632 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido
NCT00331214 ·Status: COMPLETED ·Phase: PHASE3
-
Vaginal and Urinary Microbiome Trial
NCT02869165 ·Status: COMPLETED ·Phase: PHASE4
-
Preventing Recurrent UTI With Vaginal Estrogen
NCT05551949 ·Status: COMPLETED ·Phase: PHASE4
-
Development and Evaluation of a Hormone Replacement Therapy Decision-Aid
NCT00012909 ·Status: COMPLETED ·Phase: NA
-
Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women
NCT01958073 ·Status: COMPLETED ·Phase: PHASE4